Hereditary Angioedema: Management Updates for the Specialty Pharmacist
This continuing education activity is supported by an educational grant from Takeda.
THIS ACTIVITY IS SUPPORTED BY AN EDUCATIONAL GRANT FROM TAKEDA.
Melanie B. Radi, PharmD, CSP
Manager, Clinical Programs Specialty Clinical Services
AllianceRx Walgreens Prime
At the completion of this activity, the participant will be able to:
- Characterize the diagnosis and background of hereditary angioedema (HAE) and the significance of early intervention
- Examine the clinical data of FDA-approved agents and emerging therapies for acute treatment and prophylaxis of HAE
- Explore the need for individualized treatment and the role of the specialty pharmacist in patient education for effective HAE management
TARGET AUDIENCE: Pharmacists
ACTIVITY TYPE: Application
RELEASE DATE: May 15, 2020
EXPIRATION DATE: May 15, 2021
ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours
FEE: This lesson is offered for free at www.pharmacytimes.org.